* Newstin.com is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.com and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.com is for sale! *
Full Coverage

Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal...

Jul 8, 2008
Story Timeline:  97 days

Tuesday July 8, 7:15 am ET Anika's HA-based Dermal Filler Incorporating Lidocaine to be Distributed by Artes Medical BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ:ANIK - News), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed an exclusive agreement with Artes Medical, Inc. (NASDAQ:ARTE - News ), a medical aesthetics company, to distribute and market ELEVESS™, Anika’s cross-linked hyaluronic acid-based (HA) injectable dermal filler. ELEVESS is an injectable filler that reduces the appearance of facial wrinkles and folds such as nasolabial folds, and is the first HA-based dermal filler approved by the Food and Drug Administration (“FDA”) to incorporate the anesthetic lidocaine to improve patient comfort. Artes Medical... [read full story]                    

Add Comment
Latest article on this story:

Anika Therapeutics Earnings Call scheduled for Wed, July 23 (CCBN)

yahoo.com Jul 10, 2008
First article on this story:

Artes Medical Broadens Product Portfolio Through Exclusive U.S. Sales and Marketing Agreement for...

centredaily.com Jul 8, 2008
Selected publications with coverage of this story:
RELATED